Phase II Study to Assess the Activity of Nexrutine in Prostate Cancer Patients Undergoing Surgery or Radiation Therapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Phellodendron (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 11 Jun 2015 Biomarkers information updated
- 13 Dec 2013 Planned End Date changed from 1 Dec 2019 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 13 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.